Description:
FRAGILE X MENTAL RETARDATION SYNDROME
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Chromosome Abnormalities |
Class |
Disorders with Trinucleotide Expansions |
Class |
X Chromosome Markers |
Quantity |
25 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
DNA from LCL
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
GENE MAPPING & DOSAGE STUDIES - Y CHROMOSOME |
PCR analysis of DNA from this cell culture gave a negative result with a primer for Yq11, DYS227. |
|
Remarks |
Developmental delay; FMR1 CGG repeats are 28(+/-3) on 1 chromosome and 49(+/-3) for the other X chromosome; subject does not have mental retardation but 1 allele is at the upper limit of normal |
Suganuma T, Workman JL, MPTAC links alkylation damage signaling to sterol biosynthesis Redox biology51:102270 2021 |
PubMed ID: 35189552 |
|
O'Connell CD, Atha DH, Jakupciak JP, Amos JA, Richie K, Standardization of PCR amplification for fragile X trinucleotide repeat measurements. Clin Genet61(1):13-20 2002 |
PubMed ID: 11903349 |
|
|